Moderna(@moderna_tx):Today we announced that the U.S. Food and Drug Administration has approved mFLUSIVA® (mRNA-1010), a new vaccine against seasonal influenza, for use in all adults 50 years and older. This approval follows unanimous recommendations from the FDA's Vaccines and Related Biological Products Advisory Committee supporting mFLUSIVA for adults 50 years of age and older. Read more:

Moderna

@moderna_tx

Our mission is to deliver the greatest possible impact to people through mRNA medicines.

加入 December 2013

541 正在關注 145.4K 粉絲

Moderna@moderna_tx

2026.08.06 02:23

Today we announced that the U.S. Food and Drug Administration has approved mFLUSIVA® (mRNA-1010), a new vaccine against seasonal influenza, for use in all adults 50 years and older. This approval follows unanimous recommendations from the FDA's Vaccines and Related Biological Products Advisory Committee supporting mFLUSIVA for adults 50 years of age and older. Read more: